HSBC Holdings’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.22M | Buy |
55,549
+22,001
| +66% | +$426K | ﹤0.01% | 1762 |
|
|
2025
Q4 | $727K | Sell |
33,548
-12,041
| -26% | -$254K | ﹤0.01% | 2114 |
|
|
2025
Q3 | $839K | Sell |
45,589
-35,089
| -43% | -$626K | ﹤0.01% | 1873 |
|
|
2025
Q2 | $1.39M | Sell |
80,678
-23,022
| -22% | -$982K | ﹤0.01% | 1639 |
|
|
2025
Q1 | $6.62M | Sell |
103,700
-76,853
| -43% | -$8.09M | ﹤0.01% | 1025 |
|
|
2024
Q4 | $21.9M | Buy |
180,553
+21,914
| +14% | +$2.69M | 0.01% | 708 |
|
|
2024
Q3 | $19.9M | Buy |
158,639
+156,281
| +6,628% | +$21.6M | 0.01% | 723 |
|
|
2024
Q2 | $372K | Sell |
2,358
-47,489
| -95% | -$6.1M | ﹤0.01% | 2154 |
|
|
2024
Q1 | $6.45M | Buy |
49,847
+21,334
| +75% | +$2.61M | ﹤0.01% | 1013 |
|
|
2023
Q4 | $2.75M | Buy |
28,513
+25,998
| +1,034% | +$2.49M | ﹤0.01% | 1363 |
|
|
2023
Q3 | $305K | Buy |
2,515
+519
| +26% | +$58.7K | ﹤0.01% | 2210 |
|
|
2023
Q2 | $228K | Sell |
1,996
-16,780
| -89% | -$2.16M | ﹤0.01% | 2268 |
|
|
2023
Q1 | $2.61M | Buy |
18,776
+4,341
| +30% | +$563K | ﹤0.01% | 1405 |
|
|
2022
Q4 | $1.84M | Buy |
+14,435
| New | +$1.67M | ﹤0.01% | 1718 |
|
|
2022
Q3 | – | Sell |
-74,576
| Closed | -$5.7M | – | 3244 |
|
|
2022
Q2 | $5.7M | Buy |
74,576
+70,140
| +1,581% | +$5.16M | 0.01% | 1144 |
|
|
2022
Q1 | $351K | Sell |
4,436
-450
| -9% | -$34.5K | ﹤0.01% | 2655 |
|
|
2021
Q4 | $443K | Buy |
+4,886
| New | +$418K | ﹤0.01% | 2537 |
|
|
2021
Q3 | – | Sell |
-6,105
| Closed | -$479K | – | 3158 |
|
|
2021
Q2 | $479K | Sell |
6,105
-15,660
| -72% | -$1.19M | ﹤0.01% | 2211 |
|
|
2021
Q1 | $1.62M | Buy |
21,765
+8,754
| +67% | +$808K | ﹤0.01% | 1379 |
|
|
2020
Q4 | $2.22M | Buy |
13,011
+2,301
| +21% | +$341K | ﹤0.01% | 1296 |
|
|
2020
Q3 | $1.52M | Buy |
10,710
+8,387
| +361% | +$1.27M | ﹤0.01% | 1371 |
|
|
2020
Q2 | $372K | Sell |
2,323
-4,243
| -65% | -$577K | ﹤0.01% | 2017 |
|
|
2020
Q1 | $643K | Buy |
+6,566
| New | +$751K | ﹤0.01% | 1659 |
|
|
2019
Q3 | – | Sell |
-3,572
| Closed | -$543K | – | 3145 |
|
|
2019
Q2 | $543K | Sell |
3,572
-734
| -17% | -$89.2K | ﹤0.01% | 2023 |
|
|
2019
Q1 | $513K | Buy |
+4,306
| New | +$554K | ﹤0.01% | 2083 |
|
|
2018
Q2 | – | Sell |
-3,110
| Closed | -$230K | – | 2690 |
|
|
2018
Q1 | $230K | Sell |
3,110
-554
| -15% | -$36.9K | ﹤0.01% | 2335 |
|
|
2017
Q4 | $203K | Buy |
+3,664
| New | +$194K | ﹤0.01% | 1924 |
|
|
2017
Q1 | – | Sell |
-8,750
| Closed | -$240K | – | 2541 |
|
|
2016
Q4 | $240K | Buy |
+8,750
| New | +$351K | ﹤0.01% | 2408 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
HSBC Holdings's SRPT Position: Q1 2026 in Review
HSBC Holdings increased its Sarepta Therapeutics (SRPT) stake by 66% in Q1 2026, buying an estimated $426K and bringing the position to 55,549 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1762.
HSBC Holdings first reported a position in SRPT in Q4 2016 and has held it in 28 quarters since. The position peaked at $21.9M in Q4 2024. 340 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.
- HSBC Holdings held 55,549 shares of Sarepta Therapeutics worth $1.22M as of Q1 2026.
- HSBC Holdings bought 22,001 Sarepta Therapeutics shares in Q1 2026, an estimated $426K.
- Sarepta Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1762 holding.
- HSBC Holdings first reported a position in Sarepta Therapeutics in Q4 2016 and has held it in 28 quarters since.
- HSBC Holdings's Sarepta Therapeutics position peaked at $21.9M in Q4 2024.
- 340 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.